Top

Clinical and Experimental Nephrology

Published in:

01-06-2011 | Original Article

Environmental factors influencing the survival of chronic dialysis patients

Authors: Satoshi Ogata, Noriaki Yorioka

Published in: Clinical and Experimental Nephrology | Issue 3/2011

Abstract

Background

There have been few investigations into the effects of environmental factors on the outcome of end-stage renal disease.

Methods

We investigated factors influencing the survival of dialysis patients in each prefecture of Japan by analyzing data from the Japan Statistics Bureau and Japanese Society for Dialysis Therapy using univariate and multivariate regression analysis.

Results

Univariate analysis showed that the number of dialysis specialists (p = 0.028, r = 0.319), the density of dialysis centers (the number in relation to the area of each prefecture, p = 0.018, r = 0.344), the average annual temperature (p < 0.0001, r = 0.686), and the mortality rate of the general population with cerebrovascular disease (p = 0.014, r = −0.355) were correlated with the 1-year survival of new dialysis patients from 2005 to 2007. Multivariate regression analysis showed that the average annual temperatures were extracted as determinants of the 1-year survival rate of new dialysis patients (p < 0.0001, F = 40.11, R ² = 0.471, R ²′ = 0.460).

Conclusion

The average annual temperatures could have an influence on the survival of dialysis patients. Survival of new dialysis patients by prefecture in Japan may be influenced by environmental factors that cannot be controlled medically after the initiation of dialysis.

van Dijk PC, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, et al. Effect of general population mortality on the north−south mortality gradient in patients on replacement therapy in Europe. Kidney Int. 2007;71:53–9.CrossRef

Hall YN, Sugihara JG, Go AS, Chertow GM. Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. J Am Soc Nephrol. 2005;16:3711–20.CrossRef

Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variations in the incidence of end-stage renal failure in Japan. JAMA. 2000;284:2622–4.CrossRef

Usami T, Nakao N, Fukuda M, Takeuchi O, Kamiya Y, Yoshida A, et al. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan. Kidney Int. 2003;64:1445–9.CrossRef

Japan Statistics Bureau. Statistical observations of prefectures 2009. Tokyo, Japan: Statistical Association; 2009.

Patient Registration Committee. In: Akiba T, editor. An overview of regular dialysis treatment in Japan as of Dec. 31, 2005 CD-ROM. Tokyo, Japan: Japanese Society for Dialysis Therapy; 2006; Table 7, 9.

Patient Registration Committee. In: Tsubakihara Y, editor. An overview of regular dialysis treatment in Japan as of Dec. 31, 2006 CD-ROM. Tokyo, Japan: Japanese Society for Dialysis Therapy, 2007; Table 65, 68.

Patient Registration Committee. In: Tsubakihara Y, editor. An overview of regular dialysis treatment in Japan as of Dec. 31, 2007 CD-ROM. Tokyo, Japan: Japanese Society for Dialysis Therapy; 2008; Tables 65, 68.

Patient Registration Committee. In: Tsubakihara Y, editor. An overview of regular dialysis treatment in Japan as of Dec. 31, 2008 CD-ROM. Tokyo, Japan: Japanese Society for Dialysis Therapy; 2009; Tables 232–234.

10.

Senmon-i Meibo. http://www.jsdt.or.jp/html/specialist.html. Accessed 8 Sep 2005 (in Japanese).

11.

Usami T, Kimura G. Proposal for mapping renal failure in Japan and its application for strategy to arrest end-stage renal disease. Clin Exp Nephrol. 2006;10:8–12.CrossRef

12.

Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol. 2004;8:89–97.PubMed

13.

Wakai K. Jinkou atari mansei touseki ryouhou shinki dounyuu kanjya suu no chiikisa no kentou. J Jpn Soc Dial Ther. 2006;39(Suppl 1):S600 (Abstract) (in Japanese).

14.

Terawaki H, Nakayama M, Itoh S. A multicenter survey of awareness and eating behavior regarding salt restriction among patients receiving peritoneal dialysis in the Tohoku region. J Jpn Soc Dial Ther. 2006;39:1179–85.CrossRef

15.

Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Aqodoa LY, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int. 1999;55:2515–23.CrossRef

16.

Masakane I, Nakai S, Arizono K. Nihon kokunai no touseki chiryou ni chiikisa wa arunoka. J Jpn Soc Dial Ther. 2005;38(Suppl 1):S600 (Abstract) (in Japanese).

17.

Ogata S, Iwasaki Y, Matsuda M, Mori M, Matsuki S, Tatsukawa Y, et al. Factors influencing the survival of chronic dialysis patients in each prefecture of Japan. J Jpn Soc Dial Ther. 2007;40:255–9 (in Japanese).CrossRef

Title: Environmental factors influencing the survival of chronic dialysis patients
Authors: Satoshi Ogata
Noriaki Yorioka
Publication date: 01-06-2011
Publisher: Springer Japan
Published in: Clinical and Experimental Nephrology / Issue 3/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-010-0400-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Environmental factors influencing the survival of chronic dialysis patients

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2011

Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia

The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes

A case of femoral hemorrhage in a patient with microscopic polyangiitis with low levels of myeloperoxidase-antineutrophil cytoplasmic autoantibody

Successful steroid treatment of a patient with autosomal dominant polycystic kidney disease complicated by sarcoidosis

Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page